{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:22:09Z","timestamp":1778102529680,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.anai.2016.03.030","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:35:39Z","timestamp":1462322139000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Immune-mediated reactions to vancomycin"],"prefix":"10.1016","volume":"116","author":[{"given":"Jasmit S.","family":"Minhas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige G.","family":"Wickner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2016.03.030_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited - 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front Public Health"},{"key":"10.1016\/j.anai.2016.03.030_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.anai.2016.03.030_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.anai.2016.03.030_bib4","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","author":"Bruniera","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.anai.2016.03.030_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.SMJ.0000145300.28736.BB","article-title":"Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus","volume":"98","author":"Wynn","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.anai.2016.03.030_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.anai.2016.03.030_bib7","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.anai.2016.03.030_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Weiss","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib9","unstructured":"Weller PF. Vancomycin hypersensitivity. UpToDate. http:\/\/www.uptodate.com\/contents\/vancomycin-hypersensitivity. Accessed August 10, 2015."},{"key":"10.1016\/j.anai.2016.03.030_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaip.2015.06.017","article-title":"A\u00a0role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis","volume":"3","author":"Otani","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2016.03.030_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.anai.2014.10.007","article-title":"Emergency department diagnosis and treatment of anaphylaxis: a practice parameter","volume":"113","author":"Campbell","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2342-14-34","article-title":"Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol","volume":"14","author":"Jingu","year":"2014","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.anai.2016.03.030_bib14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1097\/00003246-199909000-00006","article-title":"Antihistamine prophylaxis permits rapid vancomycin infusion","volume":"27","author":"Renz","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.anai.2016.03.030_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40259-013-0066-x","article-title":"Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy","volume":"28","author":"Mezzano","year":"2014","journal-title":"BioDrugs"},{"key":"10.1016\/j.anai.2016.03.030_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib17","first-page":"72","article-title":"Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century","volume":"24","author":"Castells Guitart","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s15010-012-0328-4","article-title":"Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection","volume":"41","author":"Bosse","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.anai.2016.03.030_bib19","first-page":"30","article-title":"Severe vancomycin-induced anaphylactic reaction","volume":"46","author":"Kupstaite","year":"2010","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.anai.2016.03.030_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2169\/internalmedicine.45.1388","article-title":"Successful vancomycin desensitization with a combination","volume":"45","author":"Kitazawa","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.anai.2016.03.030_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00045391-200007050-00010","article-title":"Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome","volume":"7","author":"Hassaballa","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.anai.2016.03.030_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1081-1206(10)62416-7","article-title":"Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels","volume":"84","author":"Chopra","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0091-6749(97)70287-2","article-title":"Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization","volume":"100","author":"Villavicencio","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/infdis\/157.3.502","article-title":"Vancomycin and the red-man syndrome: pharmacodynamics of histamine release","volume":"157","author":"Polk","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.anai.2016.03.030_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000353584","article-title":"Linear IgA Bullous Disease Presenting As Toxic Epidermal Necrolysis: A Case Report And Review Of The Literature","volume":"227","author":"Kakar","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.anai.2016.03.030_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5144\/0256-4947.2012.01.7.1535","article-title":"Linear IgA bullous dermatosis: a rare side effect of vancomycin","volume":"33","author":"Selvaraj","year":"2013","journal-title":"Ann Saudi Med"},{"issue":"1443","key":"10.1016\/j.anai.2016.03.030_bib27","first-page":"1448","article-title":"A vesiculobullous eruption in a hospitalized patient: diagnosis: drug-induced linear IgA bullous dermatosis (LAD) with eosinophils","volume":"147","author":"Jawitz","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib28","first-page":"225","article-title":"A pentad of vancomycin reactions","volume":"9","author":"O\u2019Brien","year":"2011","journal-title":"Skinmed"},{"key":"10.1016\/j.anai.2016.03.030_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2009.03.026","article-title":"Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon","volume":"62","author":"McDonald","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archdermatol.2009.68","article-title":"Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels","volume":"145","author":"Walsh","year":"2009","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2230.2008.03011.x","article-title":"Drug-associated linear IgA disease mimicking toxic epidermal necrolysis","volume":"34","author":"Khan","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1445-5994.2008.01714.x","article-title":"Case of vancomycin-induced linear immunoglobulin A bullous dermatosis","volume":"38","author":"Senanayake","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.anai.2016.03.030_bib33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archderm.144.6.774","article-title":"A morbilliform variant of vancomycin-induced linear iga bullous dermatosis","volume":"144","author":"Billet","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib34","first-page":"12","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"8","author":"Navi","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.anai.2016.03.030_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)61454-8","article-title":"A successful challenge in a patient with vancomycin-induced linear IgA dermatosis","volume":"93","author":"Joshi","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0303-6987.2004.00190.x","article-title":"Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme","volume":"31","author":"Armstrong","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anai.2016.03.030_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1067\/mjd.2003.116","article-title":"Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis","volume":"35","author":"Dellavalle","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000441-200205000-00009","article-title":"Bullous skin disease: an unusual allergic reaction to vancomycin","volume":"323","author":"Neughebauer","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.anai.2016.03.030_bib40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2001.04492.x","article-title":"Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285","volume":"145","author":"Palmer","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0190-9622(00)90102-6","article-title":"Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency","volume":"42","author":"Klein","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00004630-200021030-00010","article-title":"Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis","volume":"21","author":"Mofid","year":"2000","journal-title":"J Burn care Rehabil"},{"key":"10.1016\/j.anai.2016.03.030_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2133.1999.03131.x","article-title":"Vancomycin-induced linear IgA bulluous disease","volume":"141","author":"Danielsen","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7326\/0003-4819-129-6-199809150-00022","article-title":"Linear IgA bullous dermatosis associated with vancomycin","volume":"129","author":"Bernstein","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anai.2016.03.030_bib45","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-129-6-199809150-00021","article-title":"Vancomycin-associated linear IgA bullous dermatosis","volume":"129","author":"Nousari","year":"1998","journal-title":"Ann Intern Med"},{"issue":"5, pt 2","key":"10.1016\/j.anai.2016.03.030_bib46","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0190-9622(96)90073-0","article-title":"Vancomycin-induced linear IgA bullous dermatosis (LABD)","volume":"34","author":"Whitworth","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.1995.01690240113019","article-title":"A bulluous eruption in an elderly woman","volume":"131","author":"Richards","year":"1995","journal-title":"Arch Dermatol"},{"issue":"2, pt 2","key":"10.1016\/j.anai.2016.03.030_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0190-9622(95)90156-6","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"32","author":"Geissmann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatology"},{"issue":"1","key":"10.1016\/j.anai.2016.03.030_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0190-9622(92)70004-Y","article-title":"Vancomycin-associated linear IgA dermatosis: a report of three cases","volume":"26","author":"Carpenter","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib51","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archderm.1988.01670080012007","article-title":"Vancomycin-induced linear IgA bullous dermatosis","volume":"124","author":"Baden","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/imj.12462","article-title":"Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome","volume":"44","author":"Young","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.anai.2016.03.030_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anai.2013.01.006","article-title":"Optimal management of DRESS syndrome in course of infectious endocarditis","volume":"110","author":"Della-Torre","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2500\/aap.2012.33.3498","article-title":"The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"33","author":"Blumenthal","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.03.030_bib55","first-page":"226","article-title":"Probable hypersensitivity reaction to vancomycin associating rash, fever and neutropenia","volume":"67","author":"Dauby","year":"2012","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.anai.2016.03.030_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1710-1492-7-16","article-title":"DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin","volume":"7","author":"O\u2019Meara","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/EJA.0b013e32832ac3a6","article-title":"Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock","volume":"26","author":"Boet","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.anai.2016.03.030_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000142729","article-title":"Vancomycin-induced DRESS syndrome in a female patient","volume":"82","author":"Vauthey","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.anai.2016.03.030_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-4632.2007.03255.x","article-title":"DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6","volume":"46","author":"Tamagawa-Mineoka","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.anai.2016.03.030_bib61","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/j.1875-9114.1997.tb03104.x","article-title":"Delayed hypersensitivity reaction to vancomycin","volume":"17","author":"Marik","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anai.2016.03.030_bib62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10157-011-0559-1","article-title":"Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis","volume":"16","author":"Htike","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.anai.2016.03.030_bib63","first-page":"139","article-title":"Biopsy proven interstitial nephritis following treatment with vancomycin: a case report","volume":"74","author":"Salazar","year":"2010","journal-title":"Conn Med"},{"key":"10.1016\/j.anai.2016.03.030_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/030097498440886","article-title":"Henoch-Schoenlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection","volume":"27","author":"Michail","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.anai.2016.03.030_bib65","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MAJ.0b013e3180a6ec1e","article-title":"Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options","volume":"334","author":"Hong","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.anai.2016.03.030_bib66","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1592\/phco.21.15.1233.33901","article-title":"Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin","volume":"21","author":"Hsu","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anai.2016.03.030_bib67","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1345\/aph.17448","article-title":"Vancomycin-induced acute interstitial nephritis","volume":"32","author":"Wai","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anai.2016.03.030_bib68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0272-6386(89)80152-0","article-title":"Tubulointerstitial nephritis due to vancomycin","volume":"14","author":"Codding","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.anai.2016.03.030_bib69","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1001\/archinte.1988.00380100037008","article-title":"Acute interstitial nephritis associated with vancomycin therapy","volume":"148","author":"Bergman","year":"1988","journal-title":"Arch Inter Med"},{"key":"10.1016\/j.anai.2016.03.030_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MJT.0b013e3181f94c27","article-title":"Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management","volume":"20","author":"Changela","year":"2013","journal-title":"Am J Ther"},{"key":"10.1016\/j.anai.2016.03.030_bib71","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1468-3083.2006.01602.x","article-title":"Toxic epidermal necrolysis after vancomycin in a patient with terminal renal insufficiency: interest for intensive haemodialysis?","volume":"20","author":"Bouaziz","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anai.2016.03.030_bib72","first-page":"131","article-title":"Toxic epidermal necrolysis secondary to vancomycin","volume":"97","author":"Chan-Tack","year":"2000","journal-title":"Mo Med"},{"key":"10.1016\/j.anai.2016.03.030_bib73","first-page":"75","article-title":"Vancomycin-induced Stevens-Johnson syndrome","volume":"17","author":"Alexander","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.030_bib74","first-page":"345","article-title":"Toxic epidermal necrolysis due to vancomycin","volume":"68","author":"Vidal","year":"1992","journal-title":"Ann Allergy"},{"key":"10.1016\/j.anai.2016.03.030_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0021-5198(19)30564-5","article-title":"Influences of everninomicin, vancomycin and teicoplanin on chemical mediator release from rat peritoneal mast cells","volume":"83","author":"Sugimoto","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.anai.2016.03.030_bib76","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin skin tests and prediction of \u201cred man syndrome\u201d in healthy volunteers","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anai.2016.03.030_bib77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.det.2011.03.022","article-title":"Clinical features, diagnosis, and pathogenesis of chronic bullous disease of childhood","volume":"29","author":"Mintz","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.anai.2016.03.030_bib79","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: a comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.anai.2016.03.030_bib81","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib82","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2016.03.030_bib83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2340\/00015555-1222","article-title":"Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms","volume":"92","author":"Wongkitisophon","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.anai.2016.03.030_bib84","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"Van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anai.2016.03.030_bib85","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A\u00a0retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2016.03.030_bib86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5414\/CN108301","article-title":"Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician","volume":"81","author":"Perazella","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.anai.2016.03.030_bib87","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.anai.2016.03.030_bib88","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.anai.2016.03.030_bib89","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/AAC.42.5.1303","article-title":"Historical yearly usage of vancomycin","volume":"42","author":"Kirst","year":"1998","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:14:26Z","timestamp":1761052466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1081120616300916"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726342984.793518356","asserted-by":"object"}]},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated reactions to vancomycin","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}